Transition of 1628C > T in mitochondrial tRNA^Val gene should not be regarded as a mutation associated with hypertrophic cardiomyopathy

Abstract

Diagnosis of hypertrophic cardiomyopathy (HCM) involved the screening for the candidate pathogenic mitochondrial DNA (mtDNA) mutations. However, a poor genotype to phenotype correction is common. Neutral polymorphisms in mt-tRNA gene are recognized as a potential cause for HCM. Thus, assigning the pathogenicity for mt-tRNA mutation is important for both clinical and genetic scientists when confronted with a disease exhibiting the clinical and biochemical features of mitochondrial dysfunction. In this report, we reassess the role of mt-tRNA^Val 1628C > T mutation in HCM expression. We first carried out a systematic search in the published database, finding out the genotype and phenotype corrections for this mutation. Moreover, we perform a phylogenetic approach to see whether this mutation is conserved or not. Most strikingly, the 1628C > T mutation is not conserved and a slight change of entropy is observed between the wild type and the mutant carrying the 1628C > T mutation. Our data indicate that the 1628C > T transition should not be regarded as a mutation associated with HCM.

• 1628C > T mutation
• HCM
• mt-tRNA^Val
• polymorphism

Declaration of interest

The authors report no conflict of interest. The authors alone are responsible for the content and writing of the paper.